Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical ...

Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...

Seismic Therapeutic, Inc., the machine learning immunology company, today announced the dosing of the first healthy subject ...

Tumours, such as some breast and ovarian cancers, can express the marker HER2. HER2 is responsible for cancer growth and is ...

Scientists at King’s College London have developed an innovative IgE antibody therapy that activates the immune system to ...

There have been hundreds of measles cases reported in the U.S. since the beginning of the year. Here's what you need to know ...

A study has established the importance of immunoglobulin A, an antibody that is part of the immune system, in generating a response to pneumonia vaccines. Researchers have found that the absence of ...